XML 36 R27.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT REPORTING (Tables)
 3 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of significant expense categories
          
Category  Three Months Ended 
   June 30, 2025   June 30, 2024 
Research and development¹  $524,000   $415,000 
General and administrative²  $735,000   $752,000 
Cash used in operating activities³  $1,715,000   $1,748,000 

 

Amounts in this table are rounded to the nearest thousand.

 

¹ Research and development expenses primarily include costs related to laboratory operations, clinical trial execution, investigational device testing, design iterations, and personnel expenses associated with research activities. These expenses may appear across different financial statement line items—such as general and administrative expense, professional fees, or payroll—but are monitored internally by the CODM as a single category.

 

² General and administrative expenses encompass overhead, clinical trial-related administrative and planning expenses, and certain manufacturing-related costs such as raw materials. These costs are not broken down further for internal reporting purposes and are reviewed as a whole.

 

³ Cash used in operating activities is the key internal performance metric tracked by the CODM to evaluate development progress, cash needs, and investment strategy in the absence of commercial revenue.